US · MDAI
Spectral AI, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Dallas, TX 75201
- Website
- spectral-ai.com
Price · as of 2024-12-31
$2.15
Market cap 42.96M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $39.10 | +1,718.6% |
| Intrinsic Value(DCF) | $0.58 | -73.02% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $9.76 | ||||
| 2022 | $10.12 | $64.68 | $1,911.95 | $0.00 | $0.00 |
| 2023 | $2.07 | $91.89 | $0.00 | $0.00 | $28.74 |
| 2024 | $1.44 | $39.10 | $500.33 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Spectral AI, Inc.'s (MDAI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $39.10
- Current price
- $2.15
- AI upside
- +1,718.6%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.58
-73.02% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MDAI | Spectral AI, Inc. | $2.15 | 42.96M | +1,719% | -73% | — | — | -1.69 | -3.56 | 0.87 | -2.21 | — | -3.56 | 44.87% | -22.25% | -51.77% | 341.85% | 101.83% | -134.42% | -0.65 | -2.22 | 0.57 | 0.43 | 0.04 | -4257.00% | 6383.00% | -3052.00% | -35.62% | -0.52 | 142.31% | 0.00% | 0.00% | 0.00% | -3.85 | -2.76 | 0.86 | -4.86 |
| COEP | Coeptis Therapeutics, Inc… | $12.04 | 42.29M | — | — | — | — | -1.87 | 6.40 | — | -2.25 | -0.32 | 7.72 | 0.00% | — | — | -290.10% | -247.64% | -128.12% | 0.44 | -25.38 | 0.23 | 0.12 | -0.09 | 58072.00% | — | -815.00% | -32.60% | -1.47 | -163.77% | 0.00% | 0.00% | 0.00% | -2.11 | -3.20 | — | -17.20 |
| CTSO | Cytosorbents Corporation | $0.75 | 47.26M | +3,558% | -47% | — | — | -2.65 | 4.95 | 1.54 | -5.17 | — | 7.47 | 70.59% | -47.16% | -58.21% | -120.52% | -49.92% | -41.18% | 2.42 | -12.00 | 2.20 | 1.08 | -1.55 | -4154.00% | 1451.00% | -3488.00% | -26.76% | -1.47 | -47.32% | 0.00% | 0.00% | 0.00% | -4.68 | -5.34 | 2.21 | -8.19 |
| ECOR | electroCore, Inc. | $7.58 | 60.61M | +1,415% | +10,410% | — | — | -8.88 | 13.99 | 4.19 | -8.96 | — | 13.99 | 84.97% | -48.30% | -47.20% | -158.63% | 945.74% | -65.00% | 0.55 | — | 1.78 | 1.46 | -0.06 | -5351.00% | 5709.00% | -5329.00% | -6.59% | -0.76 | 544.51% | 0.00% | 0.00% | 0.00% | -8.03 | -14.06 | 3.88 | -7.53 |
| EQ | Equillium, Inc. | $1.82 | 64.65M | +1,406% | -79% | — | — | -3.51 | 1.48 | 0.69 | -0.81 | — | 1.48 | 100.00% | -20.12% | -19.63% | -38.75% | 80.29% | -21.19% | 0.02 | — | 3.93 | 3.73 | 2.34 | -3947.00% | 1389.00% | -1247.00% | -67.56% | -2.99 | 185.55% | 0.00% | 0.00% | 0.00% | -0.74 | -0.32 | 0.15 | -6.59 |
| ICCM | IceCure Medical Ltd | $0.58 | 39.85M | +4,441% | -7% | — | — | -4.48 | 9.95 | 20.87 | -4.01 | — | 9.95 | 44.09% | -476.94% | -465.45% | -160.70% | -2098.40% | -105.69% | 0.07 | — | 1.95 | 1.41 | 0.46 | -625.00% | 192.00% | -282.00% | -18.39% | -2.28 | -1689.04% | 0.00% | 0.00% | 0.00% | -3.92 | -4.87 | 18.71 | -7.83 |
| IPSC | Century Therapeutics, Inc… | $2.32 | 202.78M | +1,581% | -88% | — | — | -0.41 | 0.32 | 7.82 | 0.75 | — | 0.41 | 100.00% | -2096.48% | -1920.87% | -73.14% | -320.94% | -35.46% | 0.33 | — | 1.50 | 1.47 | 0.04 | -3000.00% | 19481.00% | 804.00% | -214.09% | -0.85 | -256.24% | 0.00% | 0.00% | 10.59% | 0.61 | 0.76 | -12.74 | -3.99 |
| KPTI | Karyopharm Therapeutics I… | $9.41 | 80.34M | +75% | -59% | — | — | -0.53 | -0.36 | 0.72 | -3.04 | -0.59 | -0.36 | 95.93% | -62.10% | -134.21% | 81.86% | 81.25% | -143.71% | -0.80 | -1.98 | 1.12 | 0.98 | -1.91 | 9054.00% | 57.00% | -4095.00% | -71.87% | -0.82 | 67.51% | 0.00% | 0.00% | 0.00% | -3.03 | -3.65 | 1.88 | -23.86 |
| SRTS | Sensus Healthcare, Inc. | $4.11 | 67.51M | +2,671% | -38% | -86% | +183% | -9.71 | 1.56 | 2.73 | -5.40 | — | 1.56 | 43.18% | -37.50% | -28.09% | -14.85% | -27.07% | -13.40% | 0.01 | — | 9.72 | 5.96 | 2.16 | -21463.00% | -3426.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00% | 0.00% | -5.19 | — | 1.95 | 10.06 |
| TELA | TELA Bio, Inc. | $0.87 | 38.66M | +2,769% | +12% | — | — | -1.82 | 2.43 | 1.00 | -1.88 | — | 2.58 | 67.08% | -49.23% | -54.60% | -159.87% | -201.31% | -45.76% | 1.51 | -6.45 | 5.01 | 4.02 | 0.30 | -3480.00% | 1856.00% | 269.00% | -61.69% | -2.67 | -252.24% | 0.00% | 0.00% | 8.18% | -1.74 | -1.40 | 0.86 | -4.68 |
| TELO | Telomir Pharmaceuticals, … | $1.27 | 43.66M | — | — | — | — | -7.77 | 199.83 | — | 2652.56 | -28.50 | 199.83 | 0.00% | — | — | -810.18% | -813.89% | -542.25% | 0.15 | 2.82 | 1.94 | 1.86 | -24.43 | 2727.00% | — | 3137.00% | -3.95% | -7.45 | -337.09% | 0.00% | 0.00% | 0.99% | -10.40 | -25.11 | — | 50.93 |
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
- CEO
- Vincent Stanley Capone
- Employees
- 78
- Beta
- 0.95
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.58 ÷ $2.15) − 1 = -73.02% (DCF, example).